Hogan Lovells advises Kaia Health on $285 million sale to Sword Health

Adrienne Ellman from New York and Peter Huber from Munich, representing the global law firm Hogan Lovells, have provided counsel to Kaia Health, a digital health enterprise specializing in musculoskeletal (MSK) and pulmonary care, regarding its acquisition by Sword Health in a transaction valued at $285 million.

Read More

Baker McKenzie Cairo Advises Adenia on Landmark Majority Acquisition of Parkville

Baker McKenzie Cairo has provided counsel to Adenia Partners Ltd. (Adenia), a prominent pan-African private equity firm, regarding its agreement to purchase a majority interest in Parkville Holding B.V. (Parkville), which is recognized as one of Egypt’s leading cosmeceutical companies.

Read More

Gibson Dunn Expands London Presence with Move to One Exchange Square

Gibson Dunn will move its London office to One Exchange Square in the center of the city, demonstrating the company’s long-term dedication to the London market and enhancing its capacity to serve clients in the heart of the financial and commercial communities of the United Kingdom and Europe.

Read More

Akin Expands National Security Investigations Capabilities in Los Angeles with Addition of Former DOJ NSD Deputy Chief Sarah Gerdes

In an effort to strengthen its national security and international investigations skills on the West Coast, Akin announced today that Sarah Gerdes has joined the firm as senior counsel in its international trade practice in Los Angeles.

Read More

Arnold & Porter Advises on Dual-Currency Sustainability-Linked Financing in Chile

Recently, Banco BTG Pactual Chile, as arranger, Banco Itaú Chile, as administrative agent, and the lender syndicate received advice from Arnold & Porter about a dual-currency transaction that involved a loan of US$35 million and CLP$55 billion to Caja de Compensación de Asignación Familiar La Araucana.

Read More

Dentons advises on SK Capital´s Acquisition of Swixx BioPharma

Dentons, along with Kirkland & Ellis and Bär & Karrer, provided advice to SK Capital LP for the purchase of Swixx BioPharma Holding AG, which was valued at more than €1.5 billion.

Read More